BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
9830 results:

  • 1. [Cervical CUP Syndrome: Diagnosis and Therapy].
    Lammert A; Abo-Madyan Y; Huber L; Ludwig S; Scherl C; Rotter N
    Laryngorhinootologie; 2024 May; 103(5):371-382. PubMed ID: 38697084
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.
    Shin DS; Basak S; Veena MS; Comin-Anduix B; Bhattacharya A; Dong TS; Ko A; Han P; Jacobs J; Moatamed NA; Avila L; Pellegrini M; Wang M; Srivatsan ES
    Cancer Med; 2024 May; 13(9):e7212. PubMed ID: 38686626
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
    Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
    Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. De-Escalated Therapy and Early treatment of Recurrences in HPV-Associated head and neck cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy.
    Yarbrough WG; Schrank TP; Burtness BA; Issaeva N
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675879
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. State of the Art in 3D Culture Models Applied to Thyroid cancer.
    Prete A; Matrone A; Plebani R
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674166
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
    Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
    Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Update on Oral and Oropharyngeal cancers: A guide for oral health care providers.
    Johnson LB; Reznik AS; Villa A
    J Dent Hyg; 2024 Apr; 98(2):39-46. PubMed ID: 38649286
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor growth-arrest effect of tetrahydroquinazoline-derivative human topoisomerase II-alpha inhibitor in HPV-negative head and neck squamous cell carcinoma.
    Sarogni P; Brindani N; Zamborlin A; Gonnelli A; Menicagli M; Mapanao AK; Munafò F; De Vivo M; Voliani V
    Sci Rep; 2024 Apr; 14(1):9150. PubMed ID: 38644364
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Human papillomavirus, oropharyngeal cancer, and the latest vaccine: considerations for oral healthcare providers.
    Watt M; Li E; Closmann J; Chang O
    Gen Dent; 2024; 72(3):74-77. PubMed ID: 38640011
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
    Goto H; Oshikiri T; Kato T; Nagatani Y; Funakoshi Y; Koterazawa Y; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Minami H; Kakeji Y
    PLoS One; 2024; 19(4):e0299742. PubMed ID: 38635652
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
    Yuan Y; Fan T; Wang J; Yuan Y; Tao X
    J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.
    Raguz J; Pinto C; Pölzlbauer T; Habbeddine M; Rosskopf S; Strauß J; Just V; Schmidt S; Bidet Huang K; Stemeseder F; Schippers T; Stewart E; Jez J; Berraondo P; Orlinger KK; Lauterbach H
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631709
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.
    Montagnoli DRABS; Leite VF; Godoy YS; Lafetá VM; Junior EAP; Chaurasia A; Aguiar MCF; Abreu MHNG; Martins RC
    PLoS One; 2024; 19(4):e0302370. PubMed ID: 38630775
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
    Sasaki A; Takeda D; Kawai H; Tadokoro Y; Murakami A; Yatagai N; Arimoto S; Nagatsuka H; Akashi M; Hasegawa T
    PLoS One; 2024; 19(4):e0302194. PubMed ID: 38630690
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
    Xie L; He L; Zhang W; Wang H
    PLoS One; 2024; 19(4):e0298631. PubMed ID: 38626010
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Difference between Keratinized- and Non-Keratinized-Originating Epithelium in the Process of Immune Escape of Oral Squamous Cell Carcinoma.
    Kitsukawa Y; Fukumoto C; Hyodo T; Komiyama Y; Shiraishi R; Koike A; Yagisawa S; Kunitomi Y; Hasegawa T; Kotani W; Ishida K; Wakui T; Kawamata H
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612630
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An enzyme-free sensing platform for miRNA detection and in situ imaging in clinical samples based on DNAzyme cleavage-triggered catalytic hairpin assembly.
    Wang H; Shen M; Shen X; Liu J; Huang W; Jiang X; Liu H; Zeng S; Nan K; Cai S
    Biosens Bioelectron; 2024 Jul; 256():116279. PubMed ID: 38608496
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?
    Makowska A; Weiskirchen R
    Cells; 2024 Mar; 13(7):. PubMed ID: 38606998
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
    Deutsch F; Sais D; Keatinge N; Hill M; Tran NH; Elliott M; Tran N
    BMC Cancer; 2024 Apr; 24(1):442. PubMed ID: 38600473
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 492.